Loading…

External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?

Background: Asthma is a heterogeneous disease with a wide range of clinical phenotypes, not all of which may be encompassed in the subjects included in randomised controlled trials (RCTs). This makes it difficult for clinicians to know to what extent the evidence derived from RCTs applies to a given...

Full description

Saved in:
Bibliographic Details
Published in:Thorax 2007-03, Vol.62 (3), p.219-223
Main Authors: Travers, Justin, Marsh, Suzanne, Williams, Mathew, Weatherall, Mark, Caldwell, Brent, Shirtcliffe, Philippa, Aldington, Sarah, Beasley, Richard
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b522t-d5537a82850c08055a19688aaec184f9d81a54756c214ed10e988aac59d84b663
cites
container_end_page 223
container_issue 3
container_start_page 219
container_title Thorax
container_volume 62
creator Travers, Justin
Marsh, Suzanne
Williams, Mathew
Weatherall, Mark
Caldwell, Brent
Shirtcliffe, Philippa
Aldington, Sarah
Beasley, Richard
description Background: Asthma is a heterogeneous disease with a wide range of clinical phenotypes, not all of which may be encompassed in the subjects included in randomised controlled trials (RCTs). This makes it difficult for clinicians to know to what extent the evidence derived from RCTs applies to a given patient. Aim: To calculate the proportion of individuals with asthma who would have been eligible for the major asthma RCTs from the data of a random community survey of respiratory health. Methods: A postal survey was sent to 3500 randomly selected individuals aged 25–75 years. Respondents were invited to complete a detailed respiratory questionnaire and pulmonary function testing. Participants with current asthma were assessed against the eligibility criteria of the 17 major asthma RCTs cited in the Global Initiative for Asthma (GINA) guidelines. Findings: A total of 749 participants completed the full survey, of whom 179 had current asthma. A median 4% of participants with current asthma (range 0–36%) met the eligibility criteria for the included RCTs. A median 6% (range 0–43%) of participants with current asthma on treatment met the eligibility criteria. Interpretation: This study shows that the major asthma RCTs on which the GINA guidelines are based may have limited external validity as they have been performed on highly selected patient populations. Most of the participants with current asthma on treatment in the community would not have been eligible for these RCTs.
doi_str_mv 10.1136/thx.2006.066837
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2117157</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70222261</sourcerecordid><originalsourceid>FETCH-LOGICAL-b522t-d5537a82850c08055a19688aaec184f9d81a54756c214ed10e988aac59d84b663</originalsourceid><addsrcrecordid>eNqFkUtv1DAUhS0EokNhzQ5ZQnSBlKmdxI90AaqiFpBGZcFjwcbyOA7x4MSD7ZSZf4-jRC2wwRv76nw-uvceAJ5jtMa4oOexO6xzhOgaUcoL9gCscEl5VuQVfQhWCJUoowWjJ-BJCDuEEMeYPQYnmGFEGKtWoLs6RO0HaeGttKYx8QhdC70cGteboBuo3BC9szY9ozfSBmgGKEPsenkBo4O_OtfDxsHYaeh1GG0Mk8NULrzc7-3x7VPwqE2Vfrbcp-DL9dXn-n22-fjuQ325ybYkz2PWEFIwyXNOkEIcESJxRTmXUivMy7ZqOJakZISqHJe6wUhXk6pIUsotpcUpeDP77sdtrxulU_vSir03vfRH4aQRfyuD6cR3dyvytBpMWDI4Wwy8-znqEEVahNLWykG7MQiG8nQoTuDLf8CdG6dVBoEZx4xShnmizmdKeReC1-1dKxiJKUORMhRThmLOMP148ecE9_wSWgJeLYAMSto2paVMuOc4KSrMUOKymTMh6sOdLv0PQVnBiLj5WovNpxtWX9ffRJ741zO_7Xf_7fI30QPB1Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1781766718</pqid></control><display><type>article</type><title>External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?</title><source>PubMed Central Free</source><creator>Travers, Justin ; Marsh, Suzanne ; Williams, Mathew ; Weatherall, Mark ; Caldwell, Brent ; Shirtcliffe, Philippa ; Aldington, Sarah ; Beasley, Richard</creator><creatorcontrib>Travers, Justin ; Marsh, Suzanne ; Williams, Mathew ; Weatherall, Mark ; Caldwell, Brent ; Shirtcliffe, Philippa ; Aldington, Sarah ; Beasley, Richard</creatorcontrib><description>Background: Asthma is a heterogeneous disease with a wide range of clinical phenotypes, not all of which may be encompassed in the subjects included in randomised controlled trials (RCTs). This makes it difficult for clinicians to know to what extent the evidence derived from RCTs applies to a given patient. Aim: To calculate the proportion of individuals with asthma who would have been eligible for the major asthma RCTs from the data of a random community survey of respiratory health. Methods: A postal survey was sent to 3500 randomly selected individuals aged 25–75 years. Respondents were invited to complete a detailed respiratory questionnaire and pulmonary function testing. Participants with current asthma were assessed against the eligibility criteria of the 17 major asthma RCTs cited in the Global Initiative for Asthma (GINA) guidelines. Findings: A total of 749 participants completed the full survey, of whom 179 had current asthma. A median 4% of participants with current asthma (range 0–36%) met the eligibility criteria for the included RCTs. A median 6% (range 0–43%) of participants with current asthma on treatment met the eligibility criteria. Interpretation: This study shows that the major asthma RCTs on which the GINA guidelines are based may have limited external validity as they have been performed on highly selected patient populations. Most of the participants with current asthma on treatment in the community would not have been eligible for these RCTs.</description><identifier>ISSN: 0040-6376</identifier><identifier>EISSN: 1468-3296</identifier><identifier>DOI: 10.1136/thx.2006.066837</identifier><identifier>PMID: 17105779</identifier><identifier>CODEN: THORA7</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Thoracic Society</publisher><subject>Adult ; Aged ; Asthma ; Asthma - therapy ; Biological and medical sciences ; chronic obstructive pulmonary disease ; Chronic obstructive pulmonary disease, asthma ; Clinical trials ; COPD ; Decision making ; Female ; FEV1 ; forced expiratory volume in 1 s ; GINA ; Global Initiative for Asthma ; Humans ; Male ; Medical sciences ; Middle Aged ; Pneumology ; Questionnaires ; randomised controlled trial ; Randomized Controlled Trials as Topic - standards ; RCT ; Reproducibility of Results ; Respiratory Function Tests - methods ; Response rates</subject><ispartof>Thorax, 2007-03, Vol.62 (3), p.219-223</ispartof><rights>Copyright 2007 Thorax</rights><rights>2007 INIST-CNRS</rights><rights>Copyright: 2007 Copyright 2007 Thorax</rights><rights>Copyright © 2007 BMJ Publishing Group Ltd and British Thoracic Society.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b522t-d5537a82850c08055a19688aaec184f9d81a54756c214ed10e988aac59d84b663</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2117157/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2117157/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18539170$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17105779$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Travers, Justin</creatorcontrib><creatorcontrib>Marsh, Suzanne</creatorcontrib><creatorcontrib>Williams, Mathew</creatorcontrib><creatorcontrib>Weatherall, Mark</creatorcontrib><creatorcontrib>Caldwell, Brent</creatorcontrib><creatorcontrib>Shirtcliffe, Philippa</creatorcontrib><creatorcontrib>Aldington, Sarah</creatorcontrib><creatorcontrib>Beasley, Richard</creatorcontrib><title>External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?</title><title>Thorax</title><addtitle>Thorax</addtitle><description>Background: Asthma is a heterogeneous disease with a wide range of clinical phenotypes, not all of which may be encompassed in the subjects included in randomised controlled trials (RCTs). This makes it difficult for clinicians to know to what extent the evidence derived from RCTs applies to a given patient. Aim: To calculate the proportion of individuals with asthma who would have been eligible for the major asthma RCTs from the data of a random community survey of respiratory health. Methods: A postal survey was sent to 3500 randomly selected individuals aged 25–75 years. Respondents were invited to complete a detailed respiratory questionnaire and pulmonary function testing. Participants with current asthma were assessed against the eligibility criteria of the 17 major asthma RCTs cited in the Global Initiative for Asthma (GINA) guidelines. Findings: A total of 749 participants completed the full survey, of whom 179 had current asthma. A median 4% of participants with current asthma (range 0–36%) met the eligibility criteria for the included RCTs. A median 6% (range 0–43%) of participants with current asthma on treatment met the eligibility criteria. Interpretation: This study shows that the major asthma RCTs on which the GINA guidelines are based may have limited external validity as they have been performed on highly selected patient populations. Most of the participants with current asthma on treatment in the community would not have been eligible for these RCTs.</description><subject>Adult</subject><subject>Aged</subject><subject>Asthma</subject><subject>Asthma - therapy</subject><subject>Biological and medical sciences</subject><subject>chronic obstructive pulmonary disease</subject><subject>Chronic obstructive pulmonary disease, asthma</subject><subject>Clinical trials</subject><subject>COPD</subject><subject>Decision making</subject><subject>Female</subject><subject>FEV1</subject><subject>forced expiratory volume in 1 s</subject><subject>GINA</subject><subject>Global Initiative for Asthma</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pneumology</subject><subject>Questionnaires</subject><subject>randomised controlled trial</subject><subject>Randomized Controlled Trials as Topic - standards</subject><subject>RCT</subject><subject>Reproducibility of Results</subject><subject>Respiratory Function Tests - methods</subject><subject>Response rates</subject><issn>0040-6376</issn><issn>1468-3296</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFkUtv1DAUhS0EokNhzQ5ZQnSBlKmdxI90AaqiFpBGZcFjwcbyOA7x4MSD7ZSZf4-jRC2wwRv76nw-uvceAJ5jtMa4oOexO6xzhOgaUcoL9gCscEl5VuQVfQhWCJUoowWjJ-BJCDuEEMeYPQYnmGFEGKtWoLs6RO0HaeGttKYx8QhdC70cGteboBuo3BC9szY9ozfSBmgGKEPsenkBo4O_OtfDxsHYaeh1GG0Mk8NULrzc7-3x7VPwqE2Vfrbcp-DL9dXn-n22-fjuQ325ybYkz2PWEFIwyXNOkEIcESJxRTmXUivMy7ZqOJakZISqHJe6wUhXk6pIUsotpcUpeDP77sdtrxulU_vSir03vfRH4aQRfyuD6cR3dyvytBpMWDI4Wwy8-znqEEVahNLWykG7MQiG8nQoTuDLf8CdG6dVBoEZx4xShnmizmdKeReC1-1dKxiJKUORMhRThmLOMP148ecE9_wSWgJeLYAMSto2paVMuOc4KSrMUOKymTMh6sOdLv0PQVnBiLj5WovNpxtWX9ffRJ741zO_7Xf_7fI30QPB1Q</recordid><startdate>20070301</startdate><enddate>20070301</enddate><creator>Travers, Justin</creator><creator>Marsh, Suzanne</creator><creator>Williams, Mathew</creator><creator>Weatherall, Mark</creator><creator>Caldwell, Brent</creator><creator>Shirtcliffe, Philippa</creator><creator>Aldington, Sarah</creator><creator>Beasley, Richard</creator><general>BMJ Publishing Group Ltd and British Thoracic Society</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><general>BMJ Group</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20070301</creationdate><title>External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?</title><author>Travers, Justin ; Marsh, Suzanne ; Williams, Mathew ; Weatherall, Mark ; Caldwell, Brent ; Shirtcliffe, Philippa ; Aldington, Sarah ; Beasley, Richard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b522t-d5537a82850c08055a19688aaec184f9d81a54756c214ed10e988aac59d84b663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Asthma</topic><topic>Asthma - therapy</topic><topic>Biological and medical sciences</topic><topic>chronic obstructive pulmonary disease</topic><topic>Chronic obstructive pulmonary disease, asthma</topic><topic>Clinical trials</topic><topic>COPD</topic><topic>Decision making</topic><topic>Female</topic><topic>FEV1</topic><topic>forced expiratory volume in 1 s</topic><topic>GINA</topic><topic>Global Initiative for Asthma</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pneumology</topic><topic>Questionnaires</topic><topic>randomised controlled trial</topic><topic>Randomized Controlled Trials as Topic - standards</topic><topic>RCT</topic><topic>Reproducibility of Results</topic><topic>Respiratory Function Tests - methods</topic><topic>Response rates</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Travers, Justin</creatorcontrib><creatorcontrib>Marsh, Suzanne</creatorcontrib><creatorcontrib>Williams, Mathew</creatorcontrib><creatorcontrib>Weatherall, Mark</creatorcontrib><creatorcontrib>Caldwell, Brent</creatorcontrib><creatorcontrib>Shirtcliffe, Philippa</creatorcontrib><creatorcontrib>Aldington, Sarah</creatorcontrib><creatorcontrib>Beasley, Richard</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Thorax</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Travers, Justin</au><au>Marsh, Suzanne</au><au>Williams, Mathew</au><au>Weatherall, Mark</au><au>Caldwell, Brent</au><au>Shirtcliffe, Philippa</au><au>Aldington, Sarah</au><au>Beasley, Richard</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?</atitle><jtitle>Thorax</jtitle><addtitle>Thorax</addtitle><date>2007-03-01</date><risdate>2007</risdate><volume>62</volume><issue>3</issue><spage>219</spage><epage>223</epage><pages>219-223</pages><issn>0040-6376</issn><eissn>1468-3296</eissn><coden>THORA7</coden><abstract>Background: Asthma is a heterogeneous disease with a wide range of clinical phenotypes, not all of which may be encompassed in the subjects included in randomised controlled trials (RCTs). This makes it difficult for clinicians to know to what extent the evidence derived from RCTs applies to a given patient. Aim: To calculate the proportion of individuals with asthma who would have been eligible for the major asthma RCTs from the data of a random community survey of respiratory health. Methods: A postal survey was sent to 3500 randomly selected individuals aged 25–75 years. Respondents were invited to complete a detailed respiratory questionnaire and pulmonary function testing. Participants with current asthma were assessed against the eligibility criteria of the 17 major asthma RCTs cited in the Global Initiative for Asthma (GINA) guidelines. Findings: A total of 749 participants completed the full survey, of whom 179 had current asthma. A median 4% of participants with current asthma (range 0–36%) met the eligibility criteria for the included RCTs. A median 6% (range 0–43%) of participants with current asthma on treatment met the eligibility criteria. Interpretation: This study shows that the major asthma RCTs on which the GINA guidelines are based may have limited external validity as they have been performed on highly selected patient populations. Most of the participants with current asthma on treatment in the community would not have been eligible for these RCTs.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Thoracic Society</pub><pmid>17105779</pmid><doi>10.1136/thx.2006.066837</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0040-6376
ispartof Thorax, 2007-03, Vol.62 (3), p.219-223
issn 0040-6376
1468-3296
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2117157
source PubMed Central Free
subjects Adult
Aged
Asthma
Asthma - therapy
Biological and medical sciences
chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease, asthma
Clinical trials
COPD
Decision making
Female
FEV1
forced expiratory volume in 1 s
GINA
Global Initiative for Asthma
Humans
Male
Medical sciences
Middle Aged
Pneumology
Questionnaires
randomised controlled trial
Randomized Controlled Trials as Topic - standards
RCT
Reproducibility of Results
Respiratory Function Tests - methods
Response rates
title External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T02%3A12%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=External%20validity%20of%20randomised%20controlled%20trials%20in%20asthma:%20to%20whom%20do%20the%20results%20of%20the%20trials%20apply?&rft.jtitle=Thorax&rft.au=Travers,%20Justin&rft.date=2007-03-01&rft.volume=62&rft.issue=3&rft.spage=219&rft.epage=223&rft.pages=219-223&rft.issn=0040-6376&rft.eissn=1468-3296&rft.coden=THORA7&rft_id=info:doi/10.1136/thx.2006.066837&rft_dat=%3Cproquest_pubme%3E70222261%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b522t-d5537a82850c08055a19688aaec184f9d81a54756c214ed10e988aac59d84b663%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1781766718&rft_id=info:pmid/17105779&rfr_iscdi=true